These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
257 related articles for article (PubMed ID: 20142658)
1. The use of recombinant activated FVII in postpartum hemorrhage. Franchini M; Franchi M; Bergamini V; Montagnana M; Salvagno GL; Targher G; Lippi G Clin Obstet Gynecol; 2010 Mar; 53(1):219-27. PubMed ID: 20142658 [TBL] [Abstract][Full Text] [Related]
3. Guidelines for the use of recombinant activated factor VII in massive obstetric haemorrhage. Welsh A; McLintock C; Gatt S; Somerset D; Popham P; Ogle R Aust N Z J Obstet Gynaecol; 2008 Feb; 48(1):12-6. PubMed ID: 18275566 [TBL] [Abstract][Full Text] [Related]
4. A critical review on the use of recombinant factor VIIa in life-threatening obstetric postpartum hemorrhage. Franchini M; Franchi M; Bergamini V; Salvagno GL; Montagnana M; Lippi G Semin Thromb Hemost; 2008 Feb; 34(1):104-12. PubMed ID: 18393147 [TBL] [Abstract][Full Text] [Related]
5. Use of recombinant activated factor VII in massive postpartum haemorrhage. Bouma LS; Bolte AC; van Geijn HP Eur J Obstet Gynecol Reprod Biol; 2008 Apr; 137(2):172-7. PubMed ID: 17928129 [TBL] [Abstract][Full Text] [Related]
6. Management of Labour and Delivery in a Patient With Acquired Factor VII Deficiency With Inhibitor: A Case Report. Matei A; Dolan S; Andrews J; Rivard GÉ J Obstet Gynaecol Can; 2016 Feb; 38(2):160-3. PubMed ID: 27032741 [TBL] [Abstract][Full Text] [Related]
7. Successful management by recombinant activated factor VII in a case of disseminated intravascular coagulopathy caused by obstetric hemorrhage. Nohira T; Osakabe Y; Suda S; Takahashi C; Tanaka A; Ikeda K; Ikeda T; Okabe K J Obstet Gynaecol Res; 2008 Aug; 34(4 Pt 2):623-30. PubMed ID: 18840167 [TBL] [Abstract][Full Text] [Related]
8. Recombinant activated factor VII in obstetric hemorrhage: experiences from the Australian and New Zealand Haemostasis Registry. Phillips LE; McLintock C; Pollock W; Gatt S; Popham P; Jankelowitz G; Ogle R; Cameron PA; Anesth Analg; 2009 Dec; 109(6):1908-15. PubMed ID: 19923520 [TBL] [Abstract][Full Text] [Related]
9. [Our experince with the use of recombinant activated factor VII in postpartum haemorrhage]. Mostić T; Sparić R; Argirović R; Ljubić A; Bozanović T; Arsenijević L; Tomanović-Koković J; Stefanović A Srp Arh Celok Lek; 2008 Sep; 136 Suppl 3():204-9. PubMed ID: 19562869 [TBL] [Abstract][Full Text] [Related]
10. Failure of recombinant factor VIIa to correct the coagulopathy in a case of severe postpartum hemorrhage. Lewis NR; Brunker P; Lemire SJ; Kaufman RM Transfusion; 2009 Apr; 49(4):689-95. PubMed ID: 19347977 [TBL] [Abstract][Full Text] [Related]
11. Low-dose recombinant factor VIIa for massive bleeding: a single centre observational cohort study with 73 patients. Schmid P; Mordasini A; Luginbühl M; Regli B; Kohler HP; Zimmermann H; Inderbitzin D; Hirt A; Lämmle B; Alberio L Swiss Med Wkly; 2011; 141():w13213. PubMed ID: 21735365 [TBL] [Abstract][Full Text] [Related]
12. Experience with recombinant-activated factor VII in 30 patients with congenital factor VII deficiency. Brenner B; Wiis J Hematology; 2007 Feb; 12(1):55-62. PubMed ID: 17364994 [TBL] [Abstract][Full Text] [Related]
13. Recombinant factor VIIa in the management of postpartum bleeds: an audit of clinical use. Sobieszczyk S; Breborowicz GH; Platicanov V; Tanchev S; Kessler CM Acta Obstet Gynecol Scand; 2006; 85(10):1239-47. PubMed ID: 17068684 [TBL] [Abstract][Full Text] [Related]
14. [Off-label use of recombinant factor VII (rFVIIa) in teaching hospitals in Paris in 2010]. Bardon J; Fink J; de Montblanc J; Bergmann JF; Sarrut B; Benhamou D Ann Fr Anesth Reanim; 2013 Oct; 32(10):659-64. PubMed ID: 23953834 [TBL] [Abstract][Full Text] [Related]
15. Experience with recombinant activated factor VII for severe post-partum hemorrhage in Japan, investigated by Perinatology Committee, Japan Society of Obstetrics and Gynecology. Murakami M; Kobayashi T; Kubo T; Hata T; Takeda S; Masuzaki H J Obstet Gynaecol Res; 2015 Aug; 41(8):1161-8. PubMed ID: 26013425 [TBL] [Abstract][Full Text] [Related]
16. The role of recombinant activated Factor VII in major obstetric haemorrhage: the Farnborough experience. Wissa I; Ebeid E; El-Shawarby S; Chandakas S; Kamal T; Hill N J Obstet Gynaecol; 2009 Jan; 29(1):21-4. PubMed ID: 19280490 [TBL] [Abstract][Full Text] [Related]
17. The role of recombinant activated factor VII in obstetric hemorrhage. Ahonen J Curr Opin Anaesthesiol; 2012 Jun; 25(3):309-14. PubMed ID: 22473215 [TBL] [Abstract][Full Text] [Related]
18. Recombinant activated factor VII (rFVIIa/NovoSeven®) in the management of severe postpartum haemorrhage: initial report of a multicentre case series in Japan. Kobayashi T; Nakabayashi M; Yoshioka A; Maeda M; Ikenoue T Int J Hematol; 2012 Jan; 95(1):57-63. PubMed ID: 22160834 [TBL] [Abstract][Full Text] [Related]
19. Using recombinant activated factor VII, B-Lynch compression, and reversible embolization of the uterine arteries for treatment of severe conservatively intractable postpartum hemorrhage: new method for management of massive hemorrhage in cases of placenta increta. Mechsner S; Baessler K; Brunne B; Albrecht T; Hopp H; Dudenhausen JW Fertil Steril; 2008 Nov; 90(5):2012.e1-5. PubMed ID: 18462726 [TBL] [Abstract][Full Text] [Related]
20. Recombinant human factor VIIa prevents hysterectomy in severe postpartum hemorrhage: single center study. Huber AW; Raio L; Alberio L; Ghezzi F; Surbek DV J Perinat Med; 2011 Oct; 40(1):43-9. PubMed ID: 22017328 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]